Nurix Therapeutics, Inc. financial data

Symbol
NRIX on Nasdaq
Location
Brisbane, CA
Fiscal year end
30 November
Latest financial report
10-K - Q4 2025 - 28 Jan 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 636% % 25%
Debt-to-equity 31% % -20%
Return On Equity -58% % -7.2%
Return On Assets -44% % -13%
Operating Margin -195% % 56%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 102,843,012 shares 36%
Common Stock, Shares, Outstanding 101,807,484 shares 34%
Entity Public Float $807,500,000 USD -19%
Common Stock, Value, Issued $102,000 USD 34%
Weighted Average Number of Shares Outstanding, Basic 86,666,907 shares 29%
Weighted Average Number of Shares Outstanding, Diluted 86,666,907 shares 29%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $80,887,000 USD 94%
Revenue from Contract with Customer, Excluding Assessed Tax $83,980,000 USD 54%
Research and Development Expense $316,903,000 USD 43%
General and Administrative Expense $52,743,000 USD 15%
Operating Income (Loss) $285,666,000 USD -34%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $263,697,000 USD -36%
Income Tax Expense (Benefit) $760,000 USD 181%
Net Income (Loss) Attributable to Parent $264,457,000 USD -37%
Earnings Per Share, Basic -3.05 USD/shares -5.9%
Earnings Per Share, Diluted -3.05 USD/shares -5.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $246,960,000 USD 125%
Cash, Cash Equivalents, and Short-term Investments $592,900,000 USD -2.7%
Accounts Receivable, after Allowance for Credit Loss, Current $19,000,000 USD
Assets, Current $606,819,000 USD -2%
Property, Plant and Equipment, Net $22,490,000 USD 27%
Operating Lease, Right-of-Use Asset $50,517,000 USD 80%
Other Assets, Noncurrent $7,341,000 USD 132%
Assets $688,135,000 USD 2.8%
Accounts Payable, Current $11,215,000 USD -2.3%
Employee-related Liabilities, Current $21,541,000 USD 30%
Contract with Customer, Liability, Current $17,580,000 USD -54%
Liabilities, Current $86,471,000 USD -9.8%
Contract with Customer, Liability, Noncurrent $10,011,000 USD -62%
Operating Lease, Liability, Noncurrent $52,906,000 USD 161%
Liabilities $149,388,000 USD 4.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax $105,000 USD -30%
Retained Earnings (Accumulated Deficit) $1,003,226,000 USD -36%
Stockholders' Equity Attributable to Parent $538,747,000 USD 2.2%
Liabilities and Equity $688,135,000 USD 2.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $61,087,000 USD -46%
Net Cash Provided by (Used in) Financing Activities $1,473,000 USD -9.3%
Net Cash Provided by (Used in) Investing Activities $25,533,000 USD -28%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 101,807,484 shares 34%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $34,081,000 USD -608%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $79,406,000 USD -21%
Deferred Tax Assets, Valuation Allowance $331,247,000 USD 46%
Deferred Tax Assets, Gross $345,675,000 USD 48%
Operating Lease, Liability $55,730,000 USD 97%
Payments to Acquire Property, Plant, and Equipment $3,485,000 USD 21%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $264,502,000 USD -37%
Lessee, Operating Lease, Liability, to be Paid $82,497,000 USD 115%
Property, Plant and Equipment, Gross $60,272,000 USD 15%
Operating Lease, Liability, Current $2,824,000 USD -65%
Lessee, Operating Lease, Liability, to be Paid, Year Two $9,176,000 USD 215%
Lessee, Operating Lease, Liability, to be Paid, Year One $6,287,000 USD -24%
Operating Lease, Weighted Average Discount Rate, Percent 0.0691 pure 1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $18,769,000 USD 85%
Lessee, Operating Lease, Liability, to be Paid, Year Three $13,459,000 USD 350%
Deferred Tax Assets, Operating Loss Carryforwards $106,447,000 USD 16%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $32,307,000 USD 48%
Lessee, Operating Lease, Liability, to be Paid, Year Four $14,248,000 USD 364%
Operating Lease, Payments $2,151,000 USD 12%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $14,428,000 USD 137%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%